Editorial: Shaking the antitrust stick
This article was originally published in Scrip
Executive Summary
The European Commissionhas finally presented its preliminary report on why competition is not working as it should in the EU pharmaceutical sector. Is it an indictment of widespread anticompetitive activity by originator companies, or simply a compendium of figures and selective quotations that fails to address the real issues affecting access to medicines?